EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LRRK2-Mediated Neuroinflammation Induces Neuronal Dysfunctions in a Parkinson’s and Alzheimer’s Disease Cellular Model

Veronica Mutti, Giulia Carini iD, Moira Marizzoni iD, Alice Filippini, Federica Bono iD, Chiara Fiorentini iD, Samantha Saleri iD, Floriana De Cillis iD, Annamaria Cattaneo, Massimo Gennarelli, Paolo Martini iD, Isabella Russo

Biomolecules · 2025

DOI: 10.3390/biom15091322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Veronica Mutti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Alzheimer Disease, Parkinson Disease, Neurons. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic neuroinflammation plays a crucial role in the progression of neurodegenerative diseases (NDs), including Parkinson’s disease (PD) and Alzheimer’s disease (AD). Leucine-Rich Repeat Kinase 2 (LRRK2), a gene linked to familial and sporadic PD, has been positively associated with neuroinflammation in both in vitro and in vivo systems. These observations suggest that LRRK2 might actively contribute to neuronal damage and degeneration in NDs. Based on these premises, we explored the impact of LRRK2-mediated neuroinflammation on neurons in a PD- and AD-related context. We set up a cellular model composed of human induced pluripotent stem cell (hiPSC)-derived neurons (dopaminergic for PD and cholinergic for AD) exposed to inflamed glial medium [α-synuclein pre-formed fibrils (α-syn pffs) for PD and amyloid-β (Aβ)1–42 fibrils for AD] for several days. To dissect the effect of neuroinflammation, and specifically, the role of LRRK2, on neuronal functions, we first performed transcriptome analysis, and then, we validated the results at functional levels. Interestingly, we found that LRRK2-dependent neuroinflammation contributes to neuronal dysfunctions and death in both ND contexts and that LRRK2 kinase inhibition prevents these detrimental effects. Overall, our results suggest that lowering neuroinflammation through LRRK2 pharmacological inhibition might limit the progression of NDs and thus be neuroprotective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Alzheimer DiseaseParkinson DiseaseNeuronsNeuroinflammatory DiseasesHumansInduced Pluripotent Stem Cellsalpha-SynucleinAmyloid beta-PeptidesInflammation

Stichwörter der Autor:innen

Alzheimer’s diseaseLRRK2Parkinson’s diseasehiPSCneurodegenerative diseasesneuroinflammation

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanalpha-SynucleinAmyloid beta-Peptides

Autor:innen und Institutionen

  • Unit of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
  • Biological Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy.
  • Genetic Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy.
  • Unit of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
  • Department of Pharmacological and Biomolecular Sciences, University of Milan, 20122 Milan, Italy.

ORCID-Profile: Giulia Carini, Moira Marizzoni, Federica Bono, Chiara Fiorentini, Samantha Saleri, Floriana De Cillis, Paolo Martini

Förderung

  • Ministry of Health
  • Italian Ministry of Health

Zitieren

APA

Mutti, V., Carini, G., Marizzoni, M., Filippini, A., Bono, F., Fiorentini, C., Saleri, S., De Cillis, F., Cattaneo, A., Gennarelli, M., Martini, P., & Russo, I. (2025). LRRK2-Mediated Neuroinflammation Induces Neuronal Dysfunctions in a Parkinson’s and Alzheimer’s Disease Cellular Model. Biomolecules. https://doi.org/10.3390/biom15091322

Vancouver

Mutti V, Carini G, Marizzoni M, Filippini A, Bono F, Fiorentini C, et al. LRRK2-Mediated Neuroinflammation Induces Neuronal Dysfunctions in a Parkinson’s and Alzheimer’s Disease Cellular Model. Biomolecules. 2025. doi:10.3390/biom15091322

BibTeX
@article{Mutti2025,
  author = {Mutti, Veronica and Carini, Giulia and Marizzoni, Moira and Filippini, Alice and Bono, Federica and Fiorentini, Chiara and Saleri, Samantha and De Cillis, Floriana and Cattaneo, Annamaria and Gennarelli, Massimo and Martini, Paolo and Russo, Isabella},
  title = {LRRK2-Mediated Neuroinflammation Induces Neuronal Dysfunctions in a Parkinson’s and Alzheimer’s Disease Cellular Model},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15091322}
}
Kostenlos starten →